Response to Comments: MolDX: DecisionDX-Melanoma

This document is a response to comments for MolDX LCD DL38018 (L38018) and documents the comment and notice periods. The comment period was 2019-09-26 to 2019-11-10; the notice period began 2020-10-08 and the LCD became effective 2020-11-22, and the LCD title was revised to 'MolDX: Melanoma Risk Stratification Molecular Testing'.

"Comment period for MolDX: DecisionDX-Melanoma (DL38018) ran 2019-09-26 to 2019-11-10."

Sign up to see full coverage criteria, indications, and limitations.